Bank of New York Mellon Corp - MILLENDO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MILLENDO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$63,000
-47.9%
52,573
-6.8%
0.00%
Q4 2020$121,000
-19.3%
56,397
+98.5%
0.00%
Q1 2020$150,000
+14.5%
28,411
+47.0%
0.00%
Q4 2019$131,000
-4.4%
19,3280.0%0.00%
Q3 2019$137,000
-34.1%
19,328
+7.7%
0.00%
Q2 2019$208,00017,9400.00%
Other shareholders
MILLENDO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,396,615$20,949,0005.04%
GREAT POINT PARTNERS LLC 1,288,093$19,321,0001.91%
Bpifrance SA 1,078,670$16,180,0001.84%
Prosight Management, LP 270,762$4,061,0001.78%
NEA Management Company, LLC 1,766,779$26,502,0001.38%
ADAMS STREET PARTNERS LLC 459,146$6,543,0001.27%
Samsara BioCapital, LLC 45,101$677,0000.53%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 61,860$925,0000.34%
PA Capital LLC 15,263$229,0000.24%
Fondren Management LP 14,478$217,0000.17%
View complete list of MILLENDO THERAPEUTICS INC shareholders